These results indicate that ABN-B could induce cell cycle arrest at G2/M in human lung cancer cells, possibly through the combined down-regulation of cyclin B1 and CDK1 and up-regulation of p21Waf1. The gene discussed is CDK1; the disease is lung cancer.